MedTrace Logo

To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension

NCT07051811 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 213

Last updated 2025-07-04

No results posted yet for this study

Summary

This is a prospective, multicenter, blinded, randomized controlled clinical trial designed to evaluate the safety and efficacy of a single-use intravascular ultrasound ablation catheter and ultrasound ablation system in the treatment of primary hypertension.

Conditions

  • Essential Hypertension

Interventions

PROCEDURE

Intravascular Ultrasound Ablation Therapy

The single-use intravascular ultrasound ablation catheter is used in conjunction with the ultrasound ablation device to remove renal sympathetic nerves. Standardized medication regimen.

PROCEDURE

Renal Artery Angiography

Only undergo renal artery angiography. Standardized medication regimen.

Sponsors & Collaborators

  • Lepu Medical Technology (Beijing) Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-25
Primary Completion
2027-12-31
Completion
2029-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07051811 on ClinicalTrials.gov